For the quarter ending 2026-02-28, TLRY had -$15,323K decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-02-28 | 2025-08-31 | 2025-05-31 | 2025-02-28 |
|---|---|---|---|---|
| Litigation costs, net of recoveries | - | - | 17,347 | - |
| Restructuring costs | - | - | 34,283 | - |
| Transaction costs (income), net | - | - | 4,534 | - |
| Total operating expenses | - | - | 2,523,275 | - |
| Change in fair value of contingent consideration | - | - | 0 | - |
| Operating loss | - | - | -2,282,705 | - |
| Asset impairment charges | - | - | 1,396,904 | - |
| Interest expense, net | - | - | -29,952 | - |
| Other than temporary change in fair value of convertible notes receivable | - | - | 1,661 | - |
| Non-operating income (expense), net | - | - | 10,284 | - |
| Gross profit | - | - | 240,570 | - |
| Loss before income taxes | - | - | -2,302,373 | - |
| Income tax (recovery) expense | - | - | -121,017 | - |
| Net (loss) income | -68,742 | 1,513 | -1,267,895 | -793,534 |
| Deferred income tax (recovery) expense, net | 5,520 | -2,285 | -123,703 | 1,157 |
| Unrealized foreign exchange (gain) loss | 3,558 | 2,328 | 48,943 | -21,098 |
| Amortization | 32,699 | 15,561 | 34,080 | 33,546 |
| Loss (gain) on sale of capital assets | - | - | -928 | - |
| Accretion of convertible debt discount | 4,001 | 1,976 | 2,112 | 2,766 |
| Impairments | 0 | - | 1,396,904 | 699,235 |
| Other than temporary change in fair value of convertible notes receivable | 0 | - | 1,661 | 20,000 |
| General and administrative | - | - | 167,324 | - |
| Inventory valuation write down | - | - | 0 | - |
| Unrealized loss on digital assets | -378 | -8 | - | - |
| Selling | - | - | 56,039 | - |
| Other non-cash items | -2,120 | -282 | 3,706 | 1,778 |
| Amortization | - | - | 88,616 | - |
| Stock-based compensation | 26,008 | 5,052 | 6,100 | 4,035 |
| Marketing and promotion | - | - | 37,048 | - |
| Loss on long-term investments | -4,488 | 39 | -10 | -5,474 |
| Research and development | - | - | 284 | - |
| Loss (gain) on derivative instruments | 175 | -3,670 | -735 | 1,338 |
| Change in fair value of contingent consideration | 0 | -15,000 | 0 | 0 |
| Accounts receivable | 11,297 | -14,414 | 18,122 | -9,372 |
| Prepaids and other current assets | -3,416 | 7,133 | 6 | -4,788 |
| Inventory | 9,516 | 11,905 | 7,984 | -2,550 |
| Accounts payable and accrued liabilities | -15,821 | -5,127 | 15,022 | -13,132 |
| Net cash used in operating activities | -30,479 | -1,341 | -12,807 | -5,761 |
| Investment in capital and intangible assets | 13,315 | 9,523 | 6,331 | 26,586 |
| Proceeds from disposal of capital and intangible assets | 1,505 | 293 | 5,991 | 202 |
| Investment in digital assets | 0 | 1,000 | - | - |
| Sale (purchase) of marketable securities, net | 15,312 | -34,697 | -13,761 | -14,093 |
| Investment in long-term investments | 3,595 | - | - | - |
| Proceeds from long-term investments | 1,629 | - | - | - |
| Business acquisitions, net of cash acquired | 0 | - | -100 | 0 |
| Net cash used in investing activities | -29,088 | 24,467 | 13,521 | -119 |
| Share capital issued, net of cash issuance costs | 50,567 | 22,491 | 21,450 | 28,221 |
| Cash paid in lieu fractional shares | 159 | - | - | - |
| Shares effectively repurchased for employee withholding tax | - | - | 0 | - |
| Proceeds from warrants exercised | 2,367 | - | - | - |
| Proceeds from long-term debt | 0 | - | 0 | 3,450 |
| Repayment of long-term debt | 8,455 | 2,653 | -609 | 5,727 |
| Proceeds from convertible debt | - | - | 0 | 0 |
| Repayment of convertible debt | 0 | 0 | 0 | 0 |
| Repayment of lease liabilities | 1,997 | 994 | 314 | 862 |
| Net decrease in bank indebtedness | 649 | 1,004 | -3,559 | -7,011 |
| Dividend paid to nci | - | - | 1,544 | - |
| Net cash provided by financing activities | 42,972 | 19,848 | 16,642 | 18,071 |
| Effect of foreign exchange on cash and cash equivalents | 1,272 | 188 | 4,354 | -1,933 |
| Net increase (decrease) in cash and cash equivalents | -15,323 | 43,162 | 21,710 | 10,258 |
| Cash and cash equivalents, beginning of period | 264,828 | 221,666 | 199,956 | 189,698 |
| Cash and cash equivalents and restricted cash, end of period | 249,505 | 264,828 | 221,666 | 199,956 |
Tilray Brands, Inc. (TLRY)
Tilray Brands, Inc. (TLRY)